Literature Review

All posts tagged with “Research News | Journal Article.”



Health disparities in hospice - home health transitions in Hispanic older adults with co-occurring dementia and cardiovascular disease

12/28/24 at 03:15 AM

Health disparities in hospice - home health transitions in Hispanic older adults with co-occurring dementia and cardiovascular diseaseAmerican Journal of Hospice and Palliative Care; by Sharon E Bigger, Kathy Howard Grubbs, Yan Cao, Gail L Towsley; 12/24We aimed to determine if there were demographic and/or diagnostic variables associated with the frequency of transitions between skilled HH and hospice... Hispanic older adult beneficiaries with Alzheimer's disease and related dementias (ADRD) and co-occurring cardiovascular disease (CVD) had significantly higher rates of care transitions from hospice to skilled HH than other racial and ethnic groups with both diagnoses... Our findings provide evidence of disparities in care transitions from hospice to skilled HH for Hispanic older adults living with ADRD and CVD.

Read More

Estimation of cancer deaths averted from prevention, screening, and treatment efforts, 1975-2020

12/28/24 at 03:10 AM

Estimation of cancer deaths averted from prevention, screening, and treatment efforts, 1975-2020JAMA Oncology; Katrina A. B. Goddard, PhD; Eric J. Feuer, PhD; Jeanne S. Mandelblatt, MD, MPH; Rafael Meza, PhD; Theodore R. Holford, PhD; Jihyoun Jeon, PhD; Iris Lansdorp-Vogelaar, PhD; Roman Gulati, MS; Natasha K. Stout, PhD; Nadia Howlader, PhD; Amy B. Knudsen, PhD; Daniel Miller, BA; Jennifer L. Caswell-Jin, MD; Clyde B. Schechter, MD; Ruth Etzioni, PhD; Amy Trentham-Dietz, PhD; Allison W. Kurian, MD, MSc; Sylvia K. Plevritis, PhD; John M. Hampton, MS; Sarah Stein, PhD; Liyang P. Sun, MS; Asad Umar, DVM, PhD; Philip E. Castle, PhD; 12/24Overall US mortality has declined over time for most major cancer sites because of progress in prevention, screening, and treatment. Nevertheless, the reignited Cancer Moonshot goal to reduce the age-adjusted cancer mortality rate by 50% in the next 25 years will not be achieved without accelerating progress. In this model-based study using population-level cancer mortality data, an estimated 5.94 million deaths were averted from these 5 cancers [breast, cervical, colorectal, lung, and prostate] combined. Prevention and screening accounted for 8 of every 10 averted deaths, and the contribution varied by cancer site. A comprehensive plan to reduce cancer mortality includes interventions in cancer prevention, detection, diagnosis, treatment, and survivorship care.

Read More

High-risk opioid prescribing and nurse practitioner independence

12/28/24 at 03:05 AM

High-risk opioid prescribing and nurse practitioner independenceJAMA Health Forum; Lucas D. Cusimano, BS; Nicole Maestas, MPP, PhD; 12/24In 2021, more than 1 in 5 opioid overdose deaths were attributed to prescription opioids in the US, and the rate of such deaths has increased 5-fold since 1999. Concerns around excessive opioid prescribing have been used to argue against the expansion of the scope of practice of nurse practitioners (NPs) ... In this difference-in-differences analysis of opioid prescribing in 16 states, there was no change in the rates of high-risk opioid prescribing in the 6 states that adopted nurse practitioner independence compared with 10 nonadopting neighboring states during the 24 months following adoption. The study found no association between legislation that granted independence to nurse practitioners and rates of risky opioid prescribing. 

Read More

[China] Pharmacist-led management model and medication adherence among patients with chronic heart failure-A randomized clinical trial

12/28/24 at 03:05 AM

[China] Pharmacist-led management model and medication adherence among patients with chronic heart failure-A randomized clinical trialJAMA Network Open; Lingjiao Wang, MD; Yuanyuan Zhao, MD; Liping Han, MD; Huan Zhang, MD; Hejun Chen, MD; Aixia Liu, MD; Jing Yu, MD; Ran Fu, MD; Liguang Duan, MD; Feiyue An, BS; Zhimin Guo, MD; Yang Lun, BS; Chaoli Chen, BS; Fangfang Cheng, BS; Chaohui Song, BS; Haixia Gao, MD, PhD; Chunhua Zhou, MD, PhD; 12/24Chronic heart failure (CHF) is a complex clinical syndrome that affects approximately 37.7 million people and is a leading cause of morbidity and mortality worldwide. In this randomized clinical trial involving 445 patients with CHF in China, patients who were assigned to a pharmacist-led management intervention showed modest improvement in medication adherence at 52 weeks compared with patients assigned to usual care.

Read More

[India] Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain

12/28/24 at 03:00 AM

[India] Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic painInflammopharmacology; Ardra Das, Preetha Balakrishnan; 12/24Palmitoylethanolamide (PEA) is emerging as a promising therapeutic agent for neuropathic and other pain-related conditions. PEA's interaction with endocannabinoid receptors decreases the inflammatory cytokine and chemokine production and thereby a descending pain sensation. Experimental evidence shows that PEA not only reduces pain and inflammation but also lowers the need for higher dosages of other drugs hence minimizing the risk of drug toxicity. The bioavailability of PEA has been enhanced by recent technological developments, which emphasize continuous research efforts to maximize PEA's therapeutic potential in pain treatment and associated medical sectors.

Read More

Cannabidiol for scan-related anxiety in women with advanced breast cancer - A randomized clinical trial

12/28/24 at 03:00 AM

Cannabidiol for scan-related anxiety in women with advanced breast cancer-A randomized clinical trialJAMA Network Open; Manan M. Nayak, PhD, MA; Peter Chai, MD; Paul J. Catalano, ScD; William F. Pirl, MD, MPH; James A. Tulsky, MD; Stephanie C. Tung, MD; Nancy U. Lin, MD; Nicole Andrade, BA; Sabrina Johns, MPH; Clint Vaz, MD; Melissa Hughes, MSc; Ilana M. Braun, MD; 12/24The findings of this randomized clinical trial show that CBD [cannabidiol] can be used safely in women with advanced breast cancer and clinical anxiety. Although the study did not meet its primary end point comparing preingestion vs postingestion anxiety change scores between study arms, anxiety levels in the CBD arm were significantly lower 2 to 4 hours after ingestion, suggesting a possible anxiolytic effect and warranting further investigation. 

Read More

[Iran] The relationship between the quality of oncology nursing care and the resiliency and hope of patients with cancer: a cross-sectional study

12/21/24 at 03:50 AM

[Iran] The relationship between the quality of oncology nursing care and the resiliency and hope of patients with cancer: a cross-sectional studyInternational Journal of Palliative Nursing; Nadia Sedri, Mohammad Ali Zakeri, Hakimeh Sheykhasadi, Ala Shamsi, Hosna Akbari, Mostafa Hejazi, Asghar Tavan; 12/24Patients with cancer require emotional support in addition to specialised medical treatments for their physical ailments. The quality of nursing care, resilience and hope can influence a person's cancer trajectory, and understanding these factors and their relationship can be influential in improving the process for these patients. Given the interrelationship between 'resilience' and 'hope' for patients with cancer, it is necessary to focus on the factors that impact these qualities. In addition, paying attention to the concept of resilience can improve the level of hope in patients with cancer. Based on the results, it is recommended that interventions to increase QON [quality of oncology nursing] in patients with cancer be planned and implemented. 

Read More

[Australia] Why mental health clinicians are not engaging in advance care planning with older people with schizophrenia and other psychotic illnesses

12/21/24 at 03:50 AM

[Australia] Why mental health clinicians are not engaging in advance care planning with older people with schizophrenia and other psychotic illnessesPsychology Research and Behavior Management; Anne P F Wand, Aspasia Karageorge, Yucheng Zeng, Roisin Browne, Megan B Sands, Daniella Kanareck, Vasi Naganathan, Anne Meller, Carolyn M Smith, Carmelle Peisah; 12/24These clinician-identified attitudes, experiences, and barriers to engagement in ACP [advance care planning] with older people with psychotic illnesses highlight avenues of potential intervention to facilitate ACP in this cohort. Given the complexity of issues, clinicians need education and training in ACP combined with clear processes and policies to support practice. Clinician insights should be combined with the perspectives of older consumers with psychotic illnesses and their families to inform implementation of ACP. 

Read More

Silent invader: A rare case of enterobacter aerogenes empyema in a hospice patient with complex comorbidities

12/21/24 at 03:45 AM

Silent invader: A rare case of enterobacter aerogenes empyema in a hospice patient with complex comorbiditiesCureus Case Reports; Hansani Angammana, Kafayat Omadevuae, Victoria Bengualid, Rawand Khader; 11/24Enterobacter aerogenes (recently renamed Klebsiella aerogenes) is an uncommon pathogen in pleural infections and empyema, typically associated with nosocomial urinary and gastrointestinal infections. This case report describes a 69-year-old male patient with chronic kidney disease, diabetes mellitus, and other comorbidities, who developed empyema despite broad-spectrum antibiotics. Despite initial improvement with cefepime and metronidazole, the patient's respiratory status deteriorated, and due to his do not resuscitate/do not intubate (DNR/DNI) status and extensive comorbidities, no further aggressive interventions were pursued, leading to his passing. This case highlights the diagnostic and therapeutic challenges posed by E. aerogenes in pleural infections, emphasizing its rarity in pulmonary involvement and its potential for antibiotic resistance. It also underscores the importance of considering atypical pathogens in complex infections and the need for multidisciplinary management while balancing aggressive treatments with patient-centered care, particularly in end-of-life scenarios.

Read More

Stakeholder perspectives on randomized clinical trials for children with poor-prognosis cancers

12/21/24 at 03:40 AM

Stakeholder perspectives on randomized clinical trials for children with poor-prognosis cancersJAMA Network Open; Nicholas Bird, MSc; Nicole Scobie; Pablo Berlanga, MD; Patricia Blanc, MBA; Vickie Buenger, PhD; Quentin Campbell-Hewson, MBChB; Michela Casanova, MD; Steven DuBois, MD; Julia Glade Bender, MD; Ann Graham; Delphine Heenen, LLM; Christina Ip-Toma, BSc; Donna Ludwinski, BSChem; Lucas Moreno, MD; Donna Neuberg, ScD; Antonia Palmer, MASc; Xavier Paoletti, PhD; Willemijn Plieger-van Solkema, LLM; Gregory Reaman, MD; Teresa de Rojas, MD; Claudia Rossig, MD; Anja Schiel, PhD; Sara Wakeling, BA; Gilles Vassal, MD; Andrew Pearson, MD; Leona Knox, BSc; 12/24In poor-prognosis children’s cancers, new therapies may carry fresh hope for patients and parents. However, there is an absolute requirement for any new therapy to be properly evaluated to fulfill scientific, regulatory, and reimbursement requirements. Randomized clinical trials (RCTs) are considered the gold standard, but no consensus exists on how and when they should be deployed to best meet the needs of all stakeholders. The agreed-upon workshop conclusions provide a basis for key considerations while undertaking future drug development activities for children with poor-prognosis cancers, ensuring that the needs and perspectives of all stakeholders are factored in from the outset.

Read More

US FDA approval of pediatric artificial intelligence and machine learning–enabled medical devices

12/21/24 at 03:40 AM

US FDA approval of pediatric artificial intelligence and machine learning–enabled medical devicesJAMA Pediatrics; Ryan C. L. Brewster, MD; Matthew Nagy, MD, MPH; Susmitha Wunnava, PhD; Florence T. Bourgeois, MD, MPH; 12/24Despite rapid growth in the availability of AI/ML [artificial intelligence and machine learning]-enabled devices in recent years, only a small number have been authorized for pediatric use. The current regulatory framework may expose children to off-label use, differential performance of algorithms, and safety risks. Additionally, the lack of standardized reporting of pediatric device characteristics precludes informed decision-making by health care clinicians on appropriate device use. Pediatric AI/ML-enabled devices should be validated using representative datasets and should include complete and standard documentation on pediatric testing and authorization. Such changes will require cooperation across regulatory and industry stakeholders with a commitment to safe, equitable, and effective AI/ML development for children. 

Read More

Loneliness and social and emotional support among sexual and gender minority caregivers

12/21/24 at 03:25 AM

Loneliness and social and emotional support among sexual and gender minority caregiversJAMA Network Open; Zhigang Xie, PhD; Hanadi Hamadi, PhD; Kassie Terrell, PhD; Laggy George, MPH; Jennifer Wells, BA; Jiaming Liang, PhD; 12/24In the current landscape of US health care, informal unpaid caregiving provided by family members and friends is indispensable for managing diseases and ensuring long-term care in residential settings. Sexual and gender minority (SGM) adults in the US are more likely than their non-SGM counterparts to provide informal care to their family members and/or friends. Caregiving can impose substantial physical, mental, and social connection issues on caregivers.Conclusions and Relevance In this cross-sectional study of social connections, SGM adults experienced significantly higher levels of loneliness compared with straight adults, irrespective of caregiving status. 

Read More

Developing evidence-based health policy for dementia care

12/21/24 at 03:20 AM

Developing evidence-based health policy for dementia careJAMA Health Forum; Katherine Baicker, PhD; Kosali Simon, PhD; 12/24The rising prevalence of Alzheimer disease and related dementias (ADRD) represents a profound challenge to health care and long-term care systems. Promising diagnostic tools, medicines, and interventions for ADRD are on the horizon, but these medical advances will come with substantial costs. By 2050, the annual cost of care for patients with ADRD is projected to reach $1.5 trillion in the US, with 75% covered by Medicaid and Medicare. In addition to payment policy, the decision-making environment (what, when, and how information is presented and the way that different choices are framed) for both patients and clinicians will determine the quality and value of care delivered and how that varies across patient populations. With a rapidly aging population and rising prevalence of ADRD, the need for these efforts is urgent.

Read More

Mobile app–facilitated collaborative palliative care intervention for critically ill older adults-A randomized clinical trial

12/21/24 at 03:10 AM

Mobile app–facilitated collaborative palliative care intervention for critically ill older adults-A randomized clinical trialJAMA Internal Medicine; Christopher E. Cox, MD, MPH; Deepshikha C. Ashana, MD, MBA, MS; Katelyn Dempsey, MPH; Maren K. Olsen, PhD; Alice Parish, MSPH; David Casarett, MD; Kimberly S. Johnson, MD; Krista L. Haines, DO; Colleen Naglee, MD; Jason N. Katz, MD, MHS; Mashael Al-Hegelan, MD, MBA; Isaretta L. Riley, MD, MPH; Sharron L. Docherty, RN, PNP, PhD; 12/24An automated electronic health record–integrated, mobile application–based communication platform that displayed family-reported needs over 7 days, coached ICU attending physicians on addressing needs, and prompted palliative care consultation if needs were not reduced within 3 study days. In this randomized clinical trial, a collaborative, person-centered, ICU-based palliative care intervention had no effect on palliative care needs or psychological distress compared to usual care despite a higher frequency of palliative care consultations and family meetings among intervention participants.

Read More

A scoping review of end-of-life discussions and palliative care: Implications for neurological intensive care in Latin America and the Caribbean

12/21/24 at 03:05 AM

A scoping review of end-of-life discussions and palliative care: Implications for neurological intensive care in Latin America and the CaribbeanJournal of Palliative Medicine; Monica M Diaz, Lesley A Guareña, Bettsie Garcia, Christoper A Alarcon-Ruiz, Stella M Seal, Clio Rubinos, Dulce Cruz-Oliver, J Ricardo Carhuapoma; 12/24Palliative care (PC) is essential to improve quality of life for individuals with life-limiting acute neurological conditions, particularly in resource-limited settings. In Latin America and the Caribbean (LAC), there is limited health care professional training and education on PC. Our review demonstrates a need to improve PC knowledge and access to end-of-life care resources. Regional educational efforts are needed to improve PC knowledge among health care providers who care for patients with acute neurological conditions in LAC. 

Read More

Heatwaves and neurodegenerative disease

12/21/24 at 03:05 AM

Heatwaves and neurodegenerative diseaseJAMA Neurology; Indu Subramanian, MD; Ali Saad, MD; 12/24In 2012, the Global Climate and Health Alliance drafted the Doha Declaration, a call to prioritize global policies that protect health from the effects of climate change. The number of people affected by heat waves increased by around 125 million between 2000 and 2016, and global ambient temperature is expected to increase 0.9 °F (0.5 °C) per year over the next 30 years. Heat stress is an underappreciated mechanism by which climate change impacts the health of people with neurodegenerative diseases. Given the high risk of heat-related complications in people living with neurodegenerative disease, it is critical to strengthen our evidence base to understand these risks and develop targeted solutions. 

Read More

Quality of hospices used by Medicare Advantage and traditional fee-for-service beneficiaries

12/21/24 at 03:00 AM

Quality of hospices used by Medicare Advantage and traditional fee-for-service beneficiariesJAMA Network Open; Lindsay L. Y. White, PhD, MPH; Chuxuan Sun, MPA; Norma B. Coe, PhD; 12/24In this cross-sectional study including 4 215 648 decedents and 2 211 826 hospice enrollees, regular Medicare Advantage and fee-for-service beneficiaries enrolled in hospices of similar quality. However, beneficiaries in Medicare Advantage special needs plans were significantly more likely than fee-for-service beneficiaries to use hospices of inferior quality, with referral networks playing an important role in hospice quality choice. These results suggest that policymakers should consider incentivizing referrals to high-quality hospices and approaches to educating beneficiaries on identifying high-quality hospice care. 

Read More

Caregiver-Reported Quality in Hospices Owned by Private Equity Firms and Publicly Traded Companies

12/21/24 at 02:00 AM

Caregiver-Reported Quality in Hospices Owned by Private Equity Firms and Publicly Traded CompaniesJAMA; by Alexander E. Soltoff, Mark Aaron Unruh, David G. Stevenson, Dio Kavalieratos, Robert Tyler Braun; 12/17/24The US hospice industry has shifted from not-for-profit to for-profit ownership models, producing concerns aboutcare quality... Hospices owned by private equity firms (PEFs) or publicly traded companies (PTCs) performed significantly worse across CAHPS measures relative to not-for-profit and non-PEF/PTC for-profit agencies... These findings raise questions as to how patients are affected when PEFs and PTCs own hospices and suggest the need for greater transparency and accountability of hospice ownership.Publisher's note: Also see related articles by these authors: Acquisitions of Hospice Agencies by Private Equity Firms and Publicly Traded Corporations, JAMA Internal Medicine, 8/21; Changes in Diagnoses and Site of Care for Patients Receiving Hospice Care From Agencies Acquired by Private Equity Firms and Publicly Traded Companies; JAMA Network Open, 9/23.

Read More

Characteristics of patients enrolled in hospice presenting to the emergency department

12/17/24 at 03:00 AM

Characteristics of patients enrolled in hospice presenting to the emergency department American Journal of Emergency Medicine; by Kayla P Carpenter, Fernanda Bellolio, Cory Ingram, Aaron B Klassen, Sarayna S McGuire, Alisha A Morgan, Aidan F Mullan, Alexander D Ginsburg; 12/9/24, online ahead of print Emergency Departments (EDs) frequently care for patients with life-limiting illnesses, with nearly 1 in 5 patients enrolled in hospice presenting to an ED during their hospice enrollment. This study investigates the reasons patients enrolled in hospice seek care in the ED, the interventions they receive, and their outcomes. ... Patients enrolled in hospice most frequently presented to the ED for trauma [36%; with 15% for pain, 12% for catheter/tube malfunction]. Most received laboratory studies and imaging. Nearly half of patients were admitted to the hospital and short-term mortality was high, particularly for patients enrolled in hospice for needs for ED care? Ie.,

Read More

Race and ethnicity, gender, and promotion of physicians in academic medicine

12/14/24 at 03:55 AM

Race and ethnicity, gender, and promotion of physicians in academic medicineJAMA Network Open; Lauren Clark, MS; Elena Shergina, PhD; Nathalia Machado, PhD; Taneisha S. Scheuermann, PhD; Nasrin Sultana, MS; Deepika Polineni, MD; Grace H. Shih, MD; Robert D. Simari, MD; Jo A. Wick, PhD; Kimber P. Richter, PhD, MPH; 11/24Medical school faculty training the next generation of physicians do not resemble the diversity of America. Compared with the US working population, American Indian, Black, and Hispanic people are underrepresented in the physician workforce. These findings indicate that preferential promotion of White men within academic medicine continues to persist in the new millennium, with racially and ethnically diverse women experiencing greater underpromotion. To achieve a workforce that reflects the diversity of the US population, this study suggests that academic medicine needs to transform its culture and practices surrounding faculty appointments and promotions.

Read More

The patient portal messaging crisis

12/14/24 at 03:50 AM

The patient portal messaging crisisJAMA Neurology; Carrie K. Grouse, MD; Gregory J. Esper, MD, MBA; 12/24The patient portal has improved patient access to medical records and facilitated direct communication between patients and their health care teams, improving patient satisfaction, enhancing health care utilization, and increasing treatment adherence. Work associated with portal messaging has fallen primarily on physicians, requiring time outside clinical work hours to respond. Appointment access limitations have driven more asynchronous care delivery, resulting in more complex and time-consuming messages. This trend is causing higher levels of physician burnout, and female physicians are disproportionately affected. Burnout associated with excessive after-hours work in EHRs [electronic health records] is now noted among neurologists.

Read More

Redefining acute virtual care for overburdened health systems

12/14/24 at 03:45 AM

Redefining acute virtual care for overburdened health systemsJAMA Network Open; Michael J. Maniaci, MD; Richard D. Rothman, MD; Jessica A. Hohman, MD; 11/24Over the past decade, the concept of delivering acute hospital-level care in the home has gained traction, particularly with advances in telemedicine and remote patient monitoring. This retrospective cohort study compared the outcomes of 876 patients who received acute virtual care at home with outcomes of 1590 patients who were treated using traditional in-hospital care for similar conditions. The study found that the Safer@Home patients spent a mean of 4 fewer days in the hospital (1.3 vs 5.3 days), without a significant increase in 30-day readmission or mortality rates. This all-virtual model effectively avoided the use of 3505 bed-days without compromising safety, both making this an impactful exploration of alternatives to traditional inpatient care as well as offering a promising alternative for underresourced health systems unable to support in-home care.

Read More

Promoting the resilience of health care information systems—The day hospitals stood still

12/14/24 at 03:40 AM

Promoting the resilience of health care information systems—The day hospitals stood stillJAMA Health Forum; Daniel B. Kramer, MD, MPH; Kevin Fu, PhD; 11/24On Friday, July 19, 2024, health care workers woke to emails declaring systemwide information technology (IT) emergencies. Because Crowdstrike had access to the most sensitive core parts of the Windows operating system, the automated process caused an immediate global outage of computer systems using the Crowdstrike Falcon product, which is embedded in many computer systems at health care organizations. Rather than accept this event as inherent to a complex, digitized, and wired health care ecosystem, we urge the US Congress, health care regulators, and the public to insist on proactive preventive methods to avoid future IT catastrophic events rather than simply waiting for the next disruptive crisis requiring an emergent response.

Read More

Researcher explores using AI to overcome language barriers with patients

12/14/24 at 03:35 AM

Researcher explores using AI to overcome language barriers with patientsJAMA Network; Yulin Hswen, ScD, MPH; Kate Schweitzer; 12/24In the US, 25 million people with language barriers receive worse health care by nearly every standard than those who speak English fluently. In a recent Viewpoint in JAMA, K. Casey Lion, MD, MPH, an associate professor of pediatrics at the University of Washington School of Medicine, listed the poorer-quality outcomes: inferior comprehension, lower adherence, higher costs, and more frequent serious safety events, to name a few. In this study, we want to understand how it performs under real-world conditions because those are the conditions we would be using it in. I would also encourage other health care systems that are thinking about implementing AI for language access to think about talking to and involving their patients and families in the work to be sure that it’s reflecting what our patients and families actually want rather than what we think they want.

Read More

International comparison of underlying disease among recipients of medical assistance in dying

12/14/24 at 03:30 AM

International comparison of underlying disease among recipients of medical assistance in dyingJAMA Internal Medicine; Brandon Heidinger, BSc; Colleen Webber, PhD; Kenneth Chambaere, PhD; Eliana Close, PhD; Luc Deliens, PhD; Bregje Onwuteaka-Philipsen, PhD; Thaddeus Pope, JD, PhD; Agnes van der Heide, MD, PhD; Ben White, DPhil, LLB, (Hons); James Downar, MD, MHSc; 12/24In 2023, 282 million individuals lived in jurisdictions allowing medical assistance in dying (MAID). But regardless of jurisdiction, cancer and amyotrophic lateral sclerosis (ALS) consistently account for up to 80% of MAID cases, despite accounting for fewer than 30% of all deaths. This observation is consistent with the idea that MAID is driven heavily by illness-related factors common to people with those illnesses and inconsistent with the idea that MAID is driven substantially by factors that are external to the individual and that vary by jurisdiction, such as eligibility criteria, culture, social assistance, or palliative care service availability. The overall incidence of MAID increased over time (per 1 calendar year ... )

Read More